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Abstract
Hydrogels are attractive for tissue engineering applications due to their incredible versatility, but
they can be limited in cartilage tissue engineering applications due to inadequate mechanical
performance. In an effort to address this limitation, our team previously reported the drastic
improvement in the mechanical performance of interpenetrating networks (IPNs) of poly(ethylene
glycol) diacrylate (PEG-DA) and agarose relative to pure PEG-DA and agarose networks. The
goal of the current study was specifically to determine the relative importance of PEG-DA
concentration, agarose concentration, and PEG-DA molecular weight in controlling mechanical
performance, swelling characteristics, and network parameters. IPNs consistently had compressive
and shear moduli greater than the additive sum of either single network when compared to pure
PEG-DA gels with a similar PEG-DA content. IPNs withstood a maximum stress of up to 4.0 MPa
in unconfined compression, with increased PEG-DA molecular weight being the greatest
contributing factor to improved failure properties. However, aside from failure properties, PEG-
DA concentration was the most influential factor for the large majority of properties. Increasing
the agarose and PEG-DA concentrations as well as the PEG-DA molecular weight of agarose/
PEG-DA IPNs and pure PEG-DA gels improved moduli and maximum stresses by as much as an
order of magnitude or greater compared to pure PEG-DA gels in our previous studies. Although
the viability of encapsulated chondrocytes was not significantly affected by IPN formulation,
glycosaminoglycan (GAG) content was significantly influenced, with a 12-fold increase over a
three-week period in gels with a lower PEG-DA concentration. These results suggest that
mechanical performance of IPNs may be tuned with partial but not complete independence from
biological performance of encapsulated cells.
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Mechanical integrity is an important property of hydrogels used for cartilage regeneration
and is often a major barrier in usability. Progress in improving hydrogel mechanical strength
was significantly advanced with the development of a special class of interpenetrating
network (IPN) hydrogels with superior mechanical properties (termed “double-network
hydrogels”) by the research team of Gong and Osada at Hokkaido University (Japan) [1, 2].
An IPN is synthesized by constructing a single-network hydrogel (first network), soaking
the gel in a monomer solution of the second component long enough to equilibrate, and then
photopolymerizing the second network that interlocks with the first. While IPN formation
typically enhances the performance of hydrogels in biomedical applications, conventional
IPNs do not show more than additive improvement in mechanical integrity over either
individual network [1, 3]. However, double-network (DN) hydrogels exhibit mechanical
properties sometimes orders of magnitude greater than their individual components [2, 4].
Since the development of the DN hydrogel in 2003, Gong and Osada have recognized the
comparability of DN properties to native cartilage and have consequentially studied their
potential for cartilage replacement [5, 6], with other research groups following suit [7, 8].
More recently, they developed a method using a DN hydrogel to attempt in vivo articular
cartilage regeneration without the use of encapsulated cells [9]. Other studies have led to
extremely strong DN hydrogels [10, 11], though without the specific aim of cartilage repair
or regeneration. Most methods for synthesizing DN hydrogels are not compatible for cell
encapsulation, and there have been very few attempts to produce cell-laden DN gels.
Recently, Tang and coworkers [12] reported the encapsulation of chondrocytes into a DN
hydrogel made of gellan gum and carboxymethyl chitosan to evaluate the material’s
biocompatibility. Mechanical testing was also done on acellular gels, with their stiffest gel
showing a compressive modulus of ~600 kPa, which is relatively high for a cellularly-viable
gel. However, this gel permanently deformed upon compression, raising the concern for
recovery for this particular formulation. Shin and coworkers [13] recently encapsulated
fibroblasts into gelatin/gellan gum DN hydrogels to evaluate their cytocompatibility and
mechanical properties. They reported an acellular IPN that could withstand a maximum
compression of ~7 MPa and had a compressive modulus of ~110 kPa. While both studies
showed cells could survive the encapsulation process, viability was not tested beyond 1
week for Tang and coworkers and 3 days for Shin and coworkers.
Network parameters such as swelling degree and crosslinking density, which are important
in determining whether the DN hydrogels provide a microenvironment conducive to waste/
nutrient transport, have been reported for single-network hydrogels, particularly to
determine their relationship with proteoglycan distribution [14]. However, the equations for
calculating these parameters have not yet been applied to hydrogels with more than one
network for cartilage regeneration. Furthermore, because the role of cell encapsulation is to
stimulate regrowth of the patient’s own cartilage, it is also important to evaluate not only the
viability of encapsulated cells over a longer period of time but also whether the cells are
healthy and producing ECM. Additionally, reporting the fracture properties of hydrogels
meant for load-bearing tissue applications is just as essential as reporting mechanical
stiffness. Finally, encapsulated cells that produce ECM while degrading or metabolizing the
gel could potentially affect the gel’s mechanical properties, so mechanical testing on cell-
laden hydrogels is also crucial in determining whether the material is truly appropriate in
providing mechanical compensation in vivo.
Our group has recently shown that chondrocytes can survive the encapsulation process in an
IPN consisting of 2% w/v agarose and 15% w/v poly(ethylene glycol) diacrylate (PEG-DA,
MW = 2000 Da) [15, 16]. Many agarose studies have shown a high degree of success for
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cell viability and GAG production, though these constructs are severely limited by their
inferior mechanical performance. PEG-DA, a synthetic, hydrophilic polymer, has also been
widely studied for cartilage regeneration and has mechanical properties far exceeding those
of agarose. Nguyen and coworkers [17] recently released an extensive overview of the use
of PEG-DA for cartilage tissue engineering, including the concentrations, molecular
weights, methods, mechanical properties tested, and results of several research groups who
have studied PEG-based hydrogels.
While our previous studies of agarose/PEG-DA IPNs showed a large improvement in
mechanical performance compared to both single networks, we hypothesized that further
mechanical improvements would be observed by increasing the concentrations of both
networks as well as the molecular weight of PEG-DA while still maintaining cell viability.
Three PEG-DA concentrations (10%, 15%, and 20% w/v), three agarose concentrations
(“0%” for pure PEG-DA hydrogels, 2% and 5% w/v for IPNs), and three PEG-DA
molecular weights (2000, 3400, and 6000 Da) were studied in a full-factorial design for a
total of 27 formulations. Our objective was to determine which of these three factors most
significantly contributed to differences in mechanical properties, network parameters, and
swelling characteristics. Of these 27 formulations, nine representative groups were selected
for encapsulation to examine viability as well as the mechanical properties of cell-laden
scaffolds compared to their acellular counterparts, and three were further selected for
biochemical analysis.
2. Materials and Methods
2.1 Materials
High-purity PEG-DA (molecular weights 2000, 3400, and 6000 Da; purity >99%) was
purchased from SunBio (Anyang City, South Korea). 2-Hydroxyethyl agarose (Type VII)
was purchased from Sigma-Aldrich (St. Louis, MO, USA). The photoinitiator Irgacure 2959
(I-2959) was acquired from Ciba (Basel, Switzerland).
2.2 Agarose network synthesis
Agarose powder was added to phosphate-buffered saline (PBS, 0.01 M) to yield 2% and 5%
w/v solutions and autoclaved for 30 minutes. Solutions were then pipetted into cylindrical
silicon rubber molds (~5 mm diameter, ~2 mm height), pressed between glass plates, and
cooled at 4 °C for at least 10 minutes. Gels were then placed in PBS to equilibrate for at
least 24 hours before use.
2.3 PEG-DA network synthesis
Irgacure 2959 was added to a 70/30 mixture of ethanol and deionized (DI) water to create a
10% w/v photoinitiator solution. 10%, 15%, and 20% w/v solutions of PEG-DA (molecular
weight 2000, 3400, and 6000 Da each) in PBS were prepared, and 10 µL of photoinitiator
solution was added to each mL of PEG-DA solutions. The solutions were then placed in
rectangular silicon rubber molds (~2 mm height), pressed between optical glass microscope
slides, and exposed to 312 nm light (3.0 mW/m2, XL-1000, Spectronics Corp.; Lincoln, NE)
for five minutes on each side. Gel samples were cut using a 3 mm biopsy punch, and gels
were transferred to PBS to equilibrate for at least 24 hours before use.
2.4 IPN formation
Four cylindrical agarose gels were added for each mL of PEG-DA/photoinitiator solution
and soaked under constant agitation. The length of the soaking times needed for adequate
diffusion were calculated based on literature data [18] and were dependent on the PEG-DA
molecular weight (2, 3.5, and 6 hours for molecular weights of 2000, 3400, and 6000,
Rennerfeldt et al. Page 3













respectively). The agarose gels were then placed in rectangular molds (~2 mm height)
between two optical glass microscope slides and exposed to 312 nm light, 3.0 mW/m2
(XL-1000, Spectronics Corp.) for 5 minutes on each side. Samples were then cut using a 3
mm biopsy punch and added to PBS to equilibrate for at least 24 hours before use. The
formulations are reported according to the following structure: agarose concentration/PEG-
DA concentration (PEG-DA molecular weight). As an example, the formulation 2%/15%
(2k) is an IPN with 2% w/v agarose soaked in a 15% w/v PEG-DA (2000 Da molecular
weight) monomer solution prior to photopolymerization.
2.5 Chondrocyte isolation
10 ankles of 5 juvenile Chester White hogs (female, ~3 months old, ~120 lbs) were obtained
from Winchester Meat Processing, Inc. (Winchester, KS). Cells were harvested within 24
hours after slaughter following methods described in our previous publications [19, 20]. The
articular cartilage was removed manually with a scalpel and minced under sterile conditions.
The cartilage was then digested in a 2 mg/mL sterile-filtered solution of type II collagenase
(300 U/mg, Worthington Biochemical; Lakewood, NJ) for 24 hours at 37 °C. Cells were
then filtered from their ECM, centrifuged, and resuspended in culture medium consisting of
Dulbecco’s modified Eagle medium with 4.5 g/L D-glucose, 10% fetal bovine serum (FBS),
1% nonessential amino acids, 1% sodium pyruvate, and 1% penicillin-streptomycin
fungicide. Cells were fed every other day with the supplemented medium until ~90%
confluent. The medium and supplements were obtained from Invitrogen (Grand Island, NY).
Cells were not pooled until after the first passage, during the encapsulation process.
2.6 Cell encapsulation
2.6.1 Encapsulation into IPN gels—Two solutions of agarose (3% and 7.5% w/v) in
PBS were prepared and autoclaved for 30 minutes. Meanwhile, cells were detached from
their flasks with trypsin-ethylenediaminetetra acetic acid and labeled as passage 1 (P1). At
this point, P1 cells were pooled and resuspended in PBS at 30 million cells/mL to begin the
encapsulation procedure. Once cooled to 39 °C, the cell suspension was added to each
solution of molten agarose in a 1:2 ratio to produce 2% and 5% agarose solutions with a
seeding density of 10 million cells/mL. Each solution was pipetted into sterilized silicon
rubber molds (~5 mm diameter, ~2 mm height), pressed between two glass plates, and
cooled at 4 °C for 10 minutes. The cell-encapsulated gels were then added to untreated 24-
well plates (Becton Dickenson; Franklin Lakes, NJ), supplied with 1.5 mL growth medium,
and placed in a sterile 37 °C incubator. After 24 hours, gels were added to sterile-filtered
solutions of PEG-DA (10%, 15%, and 20% w/v; 2000, 3400, and 6000 Da molecular
weights) with 0.1% Irgacure photoinitiator in PBS. Formulations selected for encapsulation
are presented in Table 1. Gels were left to soak at 37 °C and constant agitation for diffusion
times dependent on the molecular weight of PEG-DA (2, 3.5, and 6 hours for molecular
weights of 2000, 3400, and 6000, respectively). Afterward, gels were placed in sterilized
rectangular silicon molds between sterilized optical glass microscope slides and exposed for
5 minutes on each side to 312 nm light (3.0 mW/cm2). Gel samples were then cut using a 3
mm biopsy punch and returned to growth media for 24 hours before analysis.
2.6.2 Encapsulation into PEG-DA gels—Sterile filtered solutions of PEG-DA (30% w/
v, 2000, 3400, and 6000 Da molecular weights) containing 0.1% photoinitiator were
combined under sterile conditions in a 2:1 ratio with cells suspended in PBS (30 million
cells/mL), yielding three solutions of 20% w/v PEG-DA with a seeding density of 10 million
cells/mL. Solutions were placed in autoclaved rectangular molds between two optical glass
microscope slides and exposed to 312 nm light (3.0 mW/cm2) for five minutes on each side.
A 3 mm biopsy punch was used to cut samples, which were then placed in growth media for
24 hours prior to analysis.
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2.7 GAG and DNA content analysis
Three of the original 27 formulations (indicated on Table 1, n=4) were analyzed for ECM
production at 0 and 3 weeks following methods recently described [16]. These formulations
were chosen based on the mechanical performance of their acellular counterparts. DNA
content was determined with a Picogreen assay (Molecular Probes; Eugene, OR), which was
used according to the manufacturer’s directions. GAG content was quantified using a
dimethylmethylene blue assay (Biocolor; Carrickfergus, Northern Ireland) and normalized
to DNA content.
2.8 Cell viability analysis
A live/dead viability cytotoxicity kit (Invitrogen) containing 4 mM calcein AM (to stain live
cells) and 2 mM ethidium homodimer-1 (to stain dead cells) was used at 24 hours, 1 week,
and 3 weeks to assess the cell viability of chondrocytes encapsulated in IPNs and PEG-DA
gels. Cylindrical constructs (n=3) were sectioned parallel to the circular face and incubated
at 37 °C in the live/dead reagents for 45 minutes before imaging. At the 24 hour (week 0)
time point, images were captured using an Eclipse TS100-F inverted microscope (Nikon
Instruments Inc.; Melville, NY) with QCapture Pro software (version 5.1). At weeks 1 and
3, Z-scans were performed to the maximum resolution depth (350–500 µ m) in areas
representative of the overall gels using a Yokugawa CSU10 spinning disk attached to an
Olympus IX 81 microscope with 561 nm excitation/585LP emission and 488 nm excitation/
515–540 nm emission filters. CellProfiler and CellProfiler Analyst software (Broad Institute;
Cambridge, MA) was used to analyze the images and determine the percent of total cells
viable at all three time points.
2.9 Mechanical analysis
Gel diameter was measured with a micrometer under a standard stereomicroscope
(approximately 10x magnification). Samples were then loaded onto an RSA-III dynamic
mechanical analyzer (TA Instruments; New Castle, DE). Samples were compressed
unconstrained to 95% of their original height or to fracture, which was measured directly
with the RSA-III. A compression rate of 0.005 mm/s, corresponding to an average of 15%/
min, was used. The compressive modulus (E) was calculated as the slope up to an x-axis
value of 10% strain of the stress versus strain curve. Using the neo-Hookean model for ideal
elastomers, the shear modulus (G) was calculated as the slope of a plot of the stress versus
(λ-1/λ2), where λ = L/L0, L=strained thickness, and L0=original thickness [21], up to a (λ-1/
λ2) value of 10 or to fracture.
2.10 Solids content characterization
Gels were created using the methods described above. Once crosslinked, gels were placed in
excess DI water for at least 24 hours, then dried for at least 72 hours in a desiccation
chamber. Each sample was weighed a total of three times using a high precision balance
(Shimadzu Corporation; Kyoto, Japan): once immediately after crosslinking (mr), once after
swelling (ms), and again after drying (md).
The dry mass (md) and swollen mass (ms) of the PEG-DA gels and IPNs (n=4) were used to
calculate the mass swelling ratio (q):
(1)
The solid fraction, q−1, was multiplied by 100 to give the total solids percentage of each gel.
The conversion of PEG-DA in the single network (SN) gels was then calculated as the PEG-
DA dry mass divided by the theoretical mass of PEG-DA in the sample before crosslinking:
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where φ0 is the original w/v fraction of monomer solution (0.10, 0.15, and 0.20), and V is
the calculated volume of the sample based on the mold thickness and biopsy punch
diameter. To estimate the conversion of PEG-DA in the IPNs, solids content
characterization was also performed on 2% and 5% w/v agarose gels (n=10) for use in the
following equation:
(3)
where κ is the partition coefficient (assumed to be 1, though can be lower), the numerator is
the estimated PEG-DA dry mass in the IPN, and the overbar denotes an average value.
Similarly, the total solids percentage of PEG-DA in IPNs was calculated by subtracting the
average total solids of agarose from the total solids of the IPNs.
2.11 Network Parameters
The equilibrium volume swelling ratio (Q) was calculated using polymer and solvent
densities[22] (ρp and ρs, respectively), where ρp for PEG is taken as 1.12 g/mL [23] and ρs
for water was assumed to be 1 g/mL:
(4)
The following equation, assuming affine network chain deformation [24], was used to
determine the effective crosslink density (ρx):
(5)
where G is the shear modulus, R is the gas constant, T is the absolute temperature, φ2,s is the
polymer volume fraction (Q−1), and φ2,r is the polymer volume fraction at network
formation. Similar to φ2,s, φ2,r was calculated taking the mathematical inverse of Equation 4,
replacing ms with the mass of the gel after crosslinking but before swelling (mr).
The molecular weight between crosslinks (Mc) was calculated using Equation 6:
(6)
The polymer-solvent interaction parameter (χ) was also calculated based on the affine model
as follows [21]:
(7)
1 is the solvent molar volume (18 g/mol).
Assuming the active network chains are composed of PEG [25–27], a mesh size (ξ) for the
PEG-DA network was calculated using methods previously described by the widely-used
equation:
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where Cn is the characteristic ratio of the polymer (taken to be 4 for PEG) [27], l is the
weighted average of the C–C and C–O backbone bond lengths (1.47 Å), and n is the number
of bonds between crosslinks, calculated as:
(9)
The molecular weight of the repeating unit (Mr) used was 44 g/mol for PEG [27], and Mc
was calculated for each gel using Equation 6.
The above equations have been widely used to characterize network structures [14, 28].
However, it is important to recognize that ρx, Mc, ξ and ξ are all empirical parameters whose
values depend upon the model used to calculate them. Theoretically, crosslink density is the
number of elastically effective junctions per unit volume, but it is well-recognized that this
cannot be correlated directly with the number of crosslinking reactions because not all such
reactions lead to elastically effective junctions, nor does it account for chain entanglement
effects [29]. Furthermore, arguments have been made that a phantom network better
approximates hydrogel network parameters than the affine model used here [30], which
would cause ρx to differ by a factor of two from the calculation based on the affine model
(Eq. 5). Flory-Rehner theory, as cited in Equation 8, is limited both by the validity of the
elasticity model used as well as the solution thermodynamics model, which yields χ – a
model known not to be especially accurate for hydrophilic polymers [21]. Additionally, the
equation for mesh size originally proposed by Peppas and Barr-Howell [31] assumes a
highly idealized network structure of uniformly crosslinked chains with a uniform
distribution of chains throughout the volume of the gel, while real gels are hetereogenous
with a variety of length scales that contribute in different ways to mechanical properties,
swelling degree, solute diffusivities and so forth [21]. Additionally, a wide variety of
methods are used to estimate Q (and therefore φ2,s) [16, 22, 24– 27, 32–34].
Nevertheless, the parameters ρx, Mc, χ and ξ as calculated here are widely used to
characterize gels and for the purposes of this study help understand which hydrogel factors
(monomer concentrations and PEG-DA molecular weight) most contribute to their
properties, however approximated. For example, crosslink density (ρx) accounts for the
effect of swelling on the modulus and thus provides a better basis for comparison of network
structures than by considering modulus alone. The molecular weight between crosslinks is
essentially a redefinition of the crosslink density whose value is more easily related to the
polymer network structure of different gel types, even when recognized as a simple
correlating parameter. The Flory-Huggins χ parameter is widely reported for different
polymers, and its comparison against previously reported values provides a useful test for
the consistency of our work with others. Finally, even though mesh size is only a model
parameter, its calculation helps with interpretation of how changes in swelling affect
molecular structure of different networks because it incorporates information about chain
conformation, which is not otherwise considered in Flory-Rehner theory for swelling.
2.12 Statistical Analysis
For statistical inference in Sections 4.1 and 4.2, a three-factor analysis of variance
(ANOVA), followed by a Tukey’s Honestly Significant Difference post hoc test, was
performed with SPSS 20.0 (IBM; Armonk, NY) on the 27 acellular experimental groups.
The test had balanced design, as four observations were taken for each group. The model
included the three factors (PEG-DA concentration, agarose concentration, and PEG-DA
Rennerfeldt et al. Page 7













molecular weight) and the possible interactions between them. The results were then plotted
for further analysis (Figures 1, 3, 5, and 6), and based on the post hoc tests, each group was
marked if it significantly differed from the other groups varying only in one factor. For each
property, the plots showed which factor had the most significant effect. Such a claim was
also supported by the ratio of the sum of squares belonging to the most influential factor
compared to the total sum of squares, which included the contribution of not only the factors
but the interactions also. We reported this ratio (termed “SS ratio” from here forward) to
indicate the significance of a factor as well. SPSS was also used to construct standard box
plots for outlier elimination. In Section 3.3 and 3.4, the statistical inference required only a
single-factor analysis of variance, followed by a Tukey’s Honestly Significant Difference
post hoc test.
3. Results
3.1 Mechanical Analysis (Acellular)
The maximum stress and maximum strain percent of all 27 formulations are displayed in
Figure 1. Some formulations did not fracture until reaching a stress of 3 to 4 MPa. A few
samples from one formulation, 2%/20% (6k), did not fracture at all with 95% compression
(Figure 2), and thus the term “maximum stress” was used rather than “fracture stress.” It has
been shown in previous studies [15, 16] that stress-strain curves for agarose/PEG-DA IPNs
show a sharp increase in slope beyond 50% strain, resulting in large standard deviations in
maximum stress for moderate standard deviations in maximum strain. Increasing PEG-DA
and agarose concentrations showed improvement in the amount of stress the gels could
withstand before failure, though few statistically significant differences were found among
groups, due in part to large standard deviations. Table 2 presents the most significant
contributing factor for each property as well as the relationship between the two. PEG-DA
molecular weight was by far the greatest contributing factor to both maximum stress (SS
ratio = 0.46) and maximum strain (SS ratio = 0.73), with increases in PEG-DA leading to an
increase in both properties.
Shear modulus (G) data are given in Figure 3a. PEG-DA concentration was statistically the
most influential factor for the shear modulus (SS ratio = 0.58) as well as for the compressive
modulus (SS ratio = 0.58), with increases in concentration leading to increases in both
elastic and shear moduli. Both moduli had a range of approximately an order of magnitude:
25 to 230 kPa for the shear modulus and 49 to 661 kPa for the compressive modulus. The
ratio of compressive modulus (E) to shear modulus (G) is shown in Figure 3b. Compression
tests on elastic hydrogels typically give E/G ratios slightly above 3 [35], which was
observed within one standard deviation for many formulations. These E/G ratios are in
agreement with our previous work on IPNs [15, 16]. Statistically, PEG-DA molecular
weight was the most significantly influential factor on E/G ratios (SS ratio = 0.41), followed
very closely by agarose concentration (SS ratio = 0.40), and increases in both led to an
increase in E/G. Representative neo-Hookean elasticity model plots of select formulations
are presented in Figure 4 to demonstrate systematic trends in E/G ratios with respect to
agarose concentration and PEG-DA molecular weight.
3.2 Solids Content Analysis (Acellular)
The acellular IPNs and PEG-DA gels were characterized for their swelling behavior (Figure
5a). Many significant differences in swelling were found among groups, and PEG-DA
concentration was the most significant contributing factor (SS ratio = 0.61). Increases in
PEG-DA concentration led to decreases in swelling, and trends generally showed an inverse
relationship between PEG-DA concentration and the shear modulus. Average mass swelling
ratios for IPNs and pure PEG-DA gels ranged from 6.0 to 14.6, and pure agarose had much
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higher degrees of swelling (38.0 ± 1.9 for 2% and 21.3 ± 1.9 for 5%). The solids content
data were used to calculate the PEG-DA apparent conversion, and agarose concentration
was by far the most significant contributing factor (SS ratio = 0.75). Pure PEG-DA gels had
a conversion ranging from 84.5% to 90.8%, while conversion in IPNs was generally much
lower (an average of 67.7 ± 4.8% for IPNs with 2% agarose and an average of 76.8 ± 10.4%
for IPNs with 5% agarose). Additionally, the total solids content was calculated for each gel,
including agarose. 2% w/v (1.96 % w/w) pure agarose gels had a solids content of 2.6 ±
0.1%, while 5% w/v (4.8% w/w) pure agarose gels had a solids content of 4.7 ± 0.5%. These
average values were subtracted from IPN total solids percentages to determine the total
PEG-DA solids content in IPNs (Figure 5b). As with apparent conversion, PEG-DA
concentration was the most significant contributing factor (SS ratio = 0.62). With the
exception of one case, IPNs had a significantly lower PEG-DA content than their
corresponding pure PEG-DA gels (p<0.05).
Data from the solids content analysis and shear modulus measurements were used to
calculate network mesh size (Figure 6a). Mesh sizes varied from 5.9 to 17.0 nm and
increased with decreasing PEG-DA concentration. Although PEG-DA concentration was
statistically the most influential factor (SS ratio = 0.49), mesh sizes also increased when a
higher PEG-DA molecular weight was used. Crosslink density is displayed in Figure 6b.
PEG-DA concentration was the factor with the most significant impact to crosslink density
as well (SS ratio = 0.38), however no significant differences among PEG-DA concentrations
were observed in IPNs with the highest PEG-DA molecular weight.
For all 27 groups (n=4), the combined average polymer-solvent interaction parameter (χ)
was 0.510 ± 0.002. Small increases were observed in the calculated polymer-solvent
interaction parameters with increases in agarose and PEG-DA concentrations as well as with
decreases in PEG-DA molecular weight, and overall the values ranged from 0.494 to 0.532.
Very few significant differences were observed when comparing three groups at a time for
each factor. However, significant differences were observed the majority of the time
between gels with PEG-DA molecular weights of 2000 and 6000 Da.
3.3 GAG Production and Cell Viability—Three formulations were selected to
determine sulfated GAG composition of cell-laden gels at 0 and 3 weeks (Figure 7a). These
formulations were chosen because 0% agarose/20% PEG-DA (2k PEG-DA molecular
weight) had the highest shear modulus and the second-highest compressive modulus out of
all 27 acellular formulations tested and 2%/20% (6k) had the highest maximum stress (4.0
MPa). 2%/10% (6k) was used as a basis of comparison for the PEG-DA concentration. The
pure PEG-DA gels did not display a statistically significant change in GAG content from 0
to 3 weeks. However, the IPNs containing 20% and 10% w/v PEG-DA showed a 4-fold and
16-fold increase, respectively, in GAG content per gel from 0 to 3 weeks. DNA content
analysis (Figure 7b) indicated that the DNA content was similar for all three groups at week
0, however samples taken from the 2%/10% (6k) group at week 3 had 69% and 78% greater
DNA content than the 2%/20% (6k) and 0%/20% (2k) groups, respectively. Therefore, the
total accumulated GAG content normalized to DNA content was also determined (Figure
7c). IPNs containing 10% PEG-DA had approximately twice the normalized GAG content
as IPNs with 20% PEG-DA, and both of the IPN groups had a higher normalized GAG
content — 12-fold and 5-fold for the 2%/10% (6k) and 2%/20% (6k) groups, respectively —
at week 3 than at week 0.
Cell viability was tested using a live/dead assay containing calcein AM (green, representing
live cells) and ethidium bromide (red, representing dead cells) fluorescent markers. A
preliminary experiment was first conducted to ensure that encapsulated cells could survive
the longest PEG-DA diffusion time (6 hours) in the highest PEG-DA concentration (20% w/
Rennerfeldt et al. Page 9













v). Figure 8 provides a representative demonstration that cells encapsulated in IPNs
containing 2% w/v agarose and 20% w/v PEG-DA (6000 Da molecular weight) maintained
high viability 24 hours after the encapsulation process despite a longer equilibration time in
a higher PEG-DA concentration than previously used. Nine formulations were then selected
for chondrocyte encapsulation to determine cell viability at 0, 1, and 3 weeks. Although
there was a high degree of variability among samples within each group at each time point,
ranging mostly from 30 to 90 percent, the majority of formulations had at least one of three
samples that remained over 50% viable three weeks after encapsulation. No statistical
significance was found among groups or time points.
3.4 Mechanical Analysis (Cell-Laden)
Unconfined compression testing was performed on cell-laden samples 0 and 3 weeks after
encapsulation. The same nine formulations were used as those selected for viability analysis.
Figure 9 displays the maximum strain percents of the gels at both time points, which were
compared to the measurements obtained on the previous acellular gels (Fig. 1a). For all nine
cell-laden groups, the maximum strain did not change from week 0 to week 3. However,
three of the nine cell-laden formulations had a lower maximum strain percent for both time
points (p<0.05) compared to their acellular counterparts, differing by as much as 30 strain
percent. The maximum stress is presented similarly in Figure 10. As with maximum strain
percent, there were no significant differences between weeks 0 and 3 for any group,
however in several cases cell-laden gels had one-half to one-seventh the maximum stress of
their corresponding acellular gels. No cell-laden groups exceeded a maximum stress of 1500
kPa, regardless of the mechanical performance of acellular gels with the same formulation.
The shear modulus of cell-laden constructs is given in Figure 11. Unlike with maximum
stress and strain percent, there were very few instances of cell-laden gels demonstrating
decreased shear and compressive moduli in comparison to their corresponding acellular gels
(p<0.05). The ratio of compressive modulus to shear modulus (E/G) is similarly reported in
Figure 12, and the same general trends were observed between acellular and cellular gels as
in shear and compressive moduli.
4. Discussion
High-strength hydrogels with the ability to encapsulate cells and provide a
microenvironment conducive to ECM production are highly desirable for the development
of cartilage regeneration methods. Although it is generally understood that synthetic
hydrogels offer polymer network tunability with the adjustment of molecular weights and
concentrations, it is important to understand the extent to which these adjustments influence
mechanical and swelling properties for better formulation design. This study provided the
degree to which three factors influenced properties of IPN hydrogels made of agarose and
PEG-DA, demonstrating that most properties, including GAG content of encapsulated cells
over a three-week period, are affected by the concentration of PEG-DA much more than the
molecular weight of PEG-DA or concentration of agarose. It should be noted, however, that
PEG-DA molecular weight was by far the most significant factor in determining the
maximum stress and percent strain the gels could withstand before fracture. Additionally,
this study demonstrated the possibility of increasing the mechanical strength of agarose-PEG
IPNs without sacrificing cell viability or activity.
Our group previously showed that agarose-PEG-DA IPNs had shear and compressive
moduli approximately four times higher than that of pure PEG-DA (molecular weight =
2000 Da) with the same starting concentration and molecular weight [15, 16]. In these
previous studies, the pure PEG-DA samples were made from the same PEG-DA monomer
solution in which the agarose gels were soaked, which reduced the PEG-DA solution
concentration and yield from the nominal (initial) solution concentration, resulting in
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approximately equal PEG-DA solids content in the IPNs and PEG-DA gels. However, in
this study, pure PEG-DA samples were prepared directly from the specified PEG-DA
concentrations, which is why there was higher PEG-DA content (Fig. 5b) in the pure PEG-
DA gels than in the IPNs (due to thermodynamic exclusion [36, 37]) in this study and not in
our previous studies. This is an important distinction because PEG-DA content was an
important contributing factor to the compressive (E) and especially shear (G) moduli in the
current study. For ease of comparison and reporting, the results in this study were organized
by formulation name, reporting the initial PEG-DA monomer concentration rather than the
final PEG-DA content of the gels. Therefore, there often appeared to be a decrease in IPN
mechanical performance when compared to PEG-DA gels of the same initial PEG-DA
monomer concentration and molecular weight. However, when mechanical properties were
compared among groups of similar final PEG-DA content, there was always an
improvement in E and G with IPNs over pure PEG-DA gels. For instance, it would be more
appropriate to compare the IPN formulation 2%/15% (2k) to the pure PEG-DA formulation
0%/10% (2k) because they had a similar average PEG-DA solids content (9.2% and 8.9%,
respectively), rather than compare the same IPN to the pure PEG-DA formulation 0%/15%
(2k), which had a much higher PEG-DA solids content (13.3%) and therefore better
mechanical performance. In this particular case, the IPN 2%/15% (2k) had a shear modulus
twice that of the PEG-DA gel 0%/10% (2k) (60.7 kPa versus 28.1 kPa) and a compressive
modulus four times higher (198.3 kPa versus 48.5 kPa). This increase was not as great as the
increase that Gong and Osada[1] demonstrated with their double-network hydrogels of
PAMPS-PAAm, or our double-network gels of methacrylated chondroitin sulfate-
polyacrylamide [38]. However, the strength of such double-network hydrogels is believed to
arise from energy dissipation through the fracturing of covalent bonds in the first network
[39], which may limit their application for load-bearing tissue engineering applications such
as cartilage regeneration. Nonetheless, the mechanical properties of agarose-PEG-DA IPNs
were still greater than the additive sum of their components when comparing gels of similar
final PEG-DA content, demonstrating synergistic gel strengthening as outlined in previous
studies [15, 16]. It was this synergistic network strengthening that led us to consider
interactions of the three factors in the statistical analysis, however the impact of a factor
while keeping the other factor(s) at any fixed level was largest for PEG-DA concentration
for most properties.
Effective transport is an important parameter in hydrogels for cell encapsulation, and
diffusion alone is generally regarded as the driving transport phenomenon in hydrogels not
subject to forced flow conditions [40]. While mesh size affects solute diffusion, it cannot be
directly observed in hydrogels using the same methods used for solids, such as scanning
electron microscopy, because of the limitations of hydrogel sample preparation [41].
However, Waters and coworkers [42, 43] have used small-angle X-ray and neutron
scattering (SAXS/SANS) to determine the network structure of PEG-based hydrogels. Their
work concluded that PEG-DA hydrogels have a heterogeneous network containing rod-like
crosslink junctions from which many PEG chains extend, analogous to a “molecular bottle
brush” morphology. Because of this heterogeneity, the correlation of the permeability of
PEG-DA hydrogels with a single length scale parameter is a gross idealization, and thus
mesh sizes reported in this study should be interpreted in telling of their correlative value
rather than an actual network dimension.
Mesh size was determined from mechanical and swelling properties, though the equations
used in this study were originally developed for single-network hydrogels. Although the
mesh sizes reported for IPN formulations were calculated from the swelling and mechanical
data for the entire gel, only the physical properties of PEG-DA (characteristic ratio,
backbone bond length, number of bonds between crosslinks, and polymer density) were
used rather than averaged values of PEG-DA and agarose. The network structure of various
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concentrations of agarose gels has been studied extensively for the last 40 years, and values
for agarose pore size have consistently been reported to be at least an order of magnitude
greater than the mesh sizes of the pure PEG-DA gels used in this study [44, 45]. Therefore,
if the two interlocked networks are completely independent of one another, the mesh size of
the PEG-DA network may be the dominant limiting factor to cell nutrient/waste transport
and diffusion of ECM molecules such as GAGs because it is so much smaller than agarose.
This method thus provides a reasonable estimate of PEG-DA network mesh size as a
correlative parameter in PEG-DA-agarose IPNs used for cell encapsulation.
Bryant and Anseth [14] investigated the impact of calculated mesh size on GAG distribution
in poly(ethylene glycol) dimethacrylate (PEG-DM) hydrogels encapsulated with young
bovine chondrocytes. While the reported mesh sizes in their study cannot be directly
compared to those in the current study due to the possible differences of calculation methods
and the lack of direct measurements, our results for mesh size and mass swelling ratio were
very similar to those of Bryant and Anseth for our pure 10% and 20% PEG-DA gels (3400
Da molecular weight), and an increase in GAG content was also seen with an increase in
calculated mesh size (or, alternatively, a decrease in crosslink density, see Equation 8).
Increasing PEG-DA concentrations led to better mechanical performance, however it also
resulted in smaller mesh sizes. Although PEG-DA concentration was the most influential
factor for mesh size, there were many formulations that had a significantly higher mesh size
(p<0.05) when the 6k PEG-DA molecular weight was used compared to lower molecular
weights. An area of future investigation may be to use a PEG-DA molecular weight even
higher than 6000 Da to determine whether it may increase the fracture performance of the
hydrogels, and/or allow for using higher concentrations of PEG-DA (which may increase
stiffness) while still possibly maintaining a reasonable crosslink density needed for proper
GAG diffusion. However, the diffusion time would need to be reasonable, as it of course
increases with molecular weight.
A preliminary study showed that the highest concentration of agarose possible for cell
encapsulation was around 5% w/v, as higher concentrations begin to gel at temperatures
greater than 37 °C. There was often an improvement (p<0.05) in E and G for IPNs
containing 5% agarose when compared to those containing 2% agarose. However, in gels
with the highest mechanical strength (those with a PEG-DA molecular weight of 6000 Da),
mesh size and swelling were significantly lower in IPNs with 5% agarose than in pure PEG-
DA gels or IPNs with 2% agarose (p<0.05). Furthermore, the high viscosity of 5% agarose
prior to gelation makes it difficult to work with during the encapsulation process. The
increase in stiffness given by IPNs with 5% agarose is likely not worth the trade-off of the
increased cost of supplies, difficulty of use, and decreased GAG distribution due to a smaller
mesh size [14], especially since the increase in agarose concentration does not significantly
improve the maximum stress.
Constructs containing cells did not differ significantly (p<0.05) in moduli from acellular gels
in most cases and generally followed the same trends with respect to network concentrations
and PEG-DA molecular weights. Furthermore, cell-laden gels did not have significantly
different shear or compressive moduli between the week 0 and 3 time points (with the
exception of one formulation in shear modulus), suggesting that decreases in mechanical
properties were not caused by long-term cell metabolism. This was true even for the 2%/
10% (6k) group, the formulation that showed a 12-fold increase in normalized GAG
deposition from 0 to 3 weeks. Ideally, cell-laden constructs would either begin with a
stiffness similar to native cartilage or approach it as ECM is produced. Although the gels did
not decrease in stiffness with the incorporation of live cells, the question remains as to
whether or not stiffness can eventually increase if given time for sufficient ECM production
in IPNs. Han and coworkers[46] recently reported that the incorporation of sulfated GAG
Rennerfeldt et al. Page 12













and type II collagen into 2% agarose constructs significantly improved their stiffness and
peak stress, especially when used in combination. However, the concentration of GAG used
was 2.5 mg/mL, which was much higher than the concentration of cell-produced GAG (0.11
mg/mL for the highest-performing group) in week 3 of the current study. The potential for
increasing the stiffness of cell-laden agarose-PEG-DA IPNs, perhaps by manipulating cell
performance, e.g., via the incorporation of methacrylated chondroitin sulfate [15] or
aggrecan [47], may be worth further investigation. Therefore, it is our expectation that both
mechanical and cell performance can be tuned semi-independently by the altering IPN
composition and bioactive moieties, respectively, while acknowledging that cell
performance over time is expected to strongly influence the long-term mechanical
performance.
The E/G ratio and degree of linearity on the stress versus strain function plot are good
measures of whether a hydrogel may be classified as an ideal elastomer. Hydrogels with an
E/G ratio of three are considered to be ideal elastomers, though they are typically slightly
above three in compression testing [35]. The trends in E/G ratios (Fig. 3b) were caused by a
systematic deviation in linearity of the stress-strain function profiles (Fig. 4), however
deviations did not typically begin until a strain function of ~4, corresponding to ~55% strain,
which still demonstrates quite ideal elastic behavior as stated in our previous work [15, 16].
The shear modulus (G, Fig. 3a) was analyzed as the slope of the stress versus strain function
(λ - 1/λ2) profiles up to the same strain function value of 10 (69% strain) for all 27
formulations to determine if, in addition to swelling and compressive modulus, there were
any systematic trends in the stress-strain function profiles. A strain function value of 10 was
used as the upper limit of the range, as pure PEG-DA gels showed a high degree of linearity
up to this value. This analysis revealed that the trends in E/G ratios (Figures 3b and 4)
increased with increasing concentrations of agarose as well as increasing PEGDA molecular
weight. The reported elevations in E/G ratios led to an underestimation in the shear modulus
(G, by an average of 10%), which in turn led to an underestimation in crosslink density (ρx,
Fig. 6b, by an average of 13%) and a concomitant overestimation in the polymer-solvent
interaction parameter (χ, by less than 1% on average), though the trends and overall
conclusions of these G-dependent parameters are essentially unaffected. It is possible that
another model for determining G, such as the Mooney-Rivlin model [48], could better fit the
stress-strain function profiles of agarose/PEG-DA IPNs. This will be the subject of further
analysis, focused on the modulus alone, rather than the larger scope of this paper.
The polymer-solvent interaction parameter (χ) is typically used as an intermediate for
calculating the molecular weight between crosslinks. Many studies on PEG derivatives [14,
17, 22, 23, 25, 28, 32, 33] have used a value of 0.426, reported by Merrill and coworkers
[49] in 1993, though more recent studies have reported values of ~0.47 under similar
conditions [50, 51]. Our calculations of all 27 formulations averaged to a value of 0.510 ±
0.002, which is in agreement with our previous work, though higher than the value typically
used. As with the E/G ratio, the calculation of χ was used for confirming the elastic ideality
of our IPNs, and the systematic increases of E/G matched those of χ. Because there were
small overestimations of χ in formulations with higher E/G ratios, the average value of χ for
all 27 formulations is reasonably higher than what has been previously used for single-
network hydrogels.
Of concern is the observation that hydrogels with the greatest fracture properties had a
significant decrease in maximum stress when encapsulated with cells. Regardless of how the
corresponding acellular gels performed, gels with encapsulated cells did not exceed a
maximum stress of 1500 kPa, suggesting a possible limit intrinsic to agarose/PEG-DA IPNs
for load-bearing applications such as cartilage tissue engineering. As previously mentioned,
stress-strain curves for these formulations increased sharply beyond a strain of 50%,
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resulting in large differences in maximum stress between cellular and acellular gels for
seemingly-small differences in maximum strain percent. Gels with the highest maximum
stress withstood over 80% strain in compression, so even slight defects could lead to
dramatically premature failure. For this reason, we recently reviewed fracture mechanics
studies of both cartilage and hydrogels and recommended alternate methods of determining
apparent fracture toughness such as a Mode I modified single edge notch test [52]. The
presence of chondrocytes may have reduced polymerization efficiency during
photopolymerization, not only because they added opacity to the gels, reducing UV intensity
but also because their size is much larger than typical distances between crosslinks in PEG-
DA hydrogels. Cho and coworkers [53] also concluded that encapsulated materials alter
PEG network formation as a result of the heterogeneity of the hydrogels, leading to
microfractures/defects that resulted in a functional pore size as high as 20 times their
calculated theoretical mesh size. The group later went on to investigate the beneficial
increased network permeability caused by the defects and determined that fewer network
defects were present in PEG gels with a higher solids content (30–40%) [54]. The presence
of cells decreasing the maximum stress demonstrates the importance of not only determining
fracture properties of cell-laden hydrogels for tissue engineering, but also of investigating
particle size and concentration when considering the addition supplemental materials to
hydrogels for purposes such as increasing cell viability or ECM production.
The exploration of higher agarose and PEG-DA concentrations as well as higher PEG-DA
molecular weights have demonstrated vastly improved (an order of magnitude, in some
instances) mechanical properties of agarose/PEG-DA IPNs and pure PEG-DA gels over our
previous studies, while maintaining cell viability and improving cell activity. By reporting
the extent to which statistically significant factors improved mechanical properties, swelling
characteristics, and network parameters, as well as displaying where the significant
differences among formulations are prevalent for each factor, we have gained a better
understanding of how to address the limitations of competing properties for IPN design.
Studies have recently reported methods for synthesizing PEG [14, 55, 56] and agarose [57,
58] networks with controllable biodegradation. These studies suggest that cell-laden
agarose-PEG-DA IPNs can likely be designed for in vivo degradation in parallel with ECM
production. A vast variety of natural biomaterials have also been studied for tissue
engineering applications [59], and additional studies that incorporate ‘raw materials’ into
agarose-PEG-DA IPNs may further enhance their already-promising properties.
5. Conclusions
This study demonstrated the possibility of mechanical strength enhancement in agarose-
PEG-DA IPNs by varying the parameters of agarose concentration, PEG-DA concentration,
and PEG-DA molecular weight. It was determined that the most significant factor in
determining IPN compressive and shear moduli was PEG-DA concentration, while the most
significant factor in determining IPN failure properties was the molecular weight of the
PEG-DA. It was also noteworthy that the IPN composition had little effect on cell
performance, with the exception of increased GAG synthesis with larger mesh sizes.
Although acellular IPNs had superior mechanical integrity compared to pure PEG-DA gels
of similar final PEG-DA content, the maximum stress of cell-laden hydrogels did not exceed
1.5 MPa, regardless of the performance of corresponding acellular formulations. This
finding demonstrates the need to explore methods to overcome this barrier, perhaps by
incorporating bioactive ‘raw materials’ for increased GAG production and maximum stress.
In the future, it is our expectation that both mechanical and cell performance can be tuned
semi-independently by the altering IPN composition and bioactive moieties, respectively,
which together with complementary strategies such as incorporating degradable sequences
may provide a new platform technology for cartilage regeneration.
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(a) Maximum stress and (b) maximum strain percent of agarose and PEG-DA IPNs with
PEG-DA molecular weights of 2000 (2k), 3400 (3.4k), and 6000 (6k) Da and agarose
concentrations of 0% (pure PEG-DA gels), 2%, and 5%. Unlike most mechanical and
swelling characteristics, PEG-DA molecular weight was the most significantly-contributing
factor for these two failure properties. Values represent mean ± standard deviation with n=4.
Values significantly different (p<0.05) from groups varying only in: #PEG-DA
concentration, +agarose concentration, *PEG-DA molecular weight.
Rennerfeldt et al. Page 18














Images of an IPN sample (2% agarose, 20% 6k PEG-DA) (a) before unconfined
compression, (b) at 50% strain, (c) at 95% strain, and (d) immediately after compression.
This particular sample had a compressive modulus of 313 kPa and withstood a stress of 4.2
MPa without fracturing. After soaking in a phosphate buffered saline solution for 1 hour, the
sample recovered to approximately 97% of its original height.
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(a) Shear modulus and (b) ratio of compressive modulus to shear modulus of agarose (Ag)
and PEG-DA IPNs. Nearly every formulation had a significantly higher shear modulus
(p<0.05) with an increase in PEG-DA concentration, while E/G generally increased with
increases in agarose concentration and PEG-DA molecular weight. Values represent mean ±
standard deviation with n=4. Values significantly different (p<0.05) among groups varying
only in: #PEG-DA concentration, +agarose concentration, *PEG-DA molecular weight.
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Representative neo-Hookean elasticity model plots of stress versus strain function,
demonstrating trends toward non-ideal elastic behavior for (a) increases in agarose
concentration and (b) increases in PEG-DA molecular weight (in IPNs). The shear modulus,
G, was taken as the slope of these plots up to a strain function value of 10 or until fracture.
An E/G ratio of 3 is considered ideal elastic behavior, as is a linear stress-strain function
profile. PEG-DA = polyethylene glycol) diacrylate, λ=L/L0, IPN = interpenetrating network,
data points after fracture omitted in panel b.
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(a) Equilibrium mass swelling ratio and (b) PEG-DA solids content. The mass swelling
ratios generally showed an inverse relationship with shear modulus (Figure 2a), and the
decreased PEG-DA content in IPNs versus pure PEG-DA gels (0% Ag) helps to explain
corresponding decreases in shear modulus. Values represent mean ± standard deviation with
n=4. Values significantly different (p<0.05) from groups varying only in: #PEG-DA
concentration, +agarose concentration, *PEG-DA molecular weight; &value significantly
higher (p<0.05) than all 26 other formulations.
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(a) Mesh size and (b) crosslink density of PEG-DA in IPNs. Both properties were most
significantly influenced by PEG-DA, though molecular weight was also an important factor.
Values represent mean ± standard deviation with n=4. Values significantly different
(p<0.05) from groups varying only in: #PEG-DA concentration, +agarose concentration,
*PEG-DA molecular weight; &value significantly higher (p<0.05) than all 26 other
formulations.
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(a) total GAG accumulated per gel, (b) DNA content per gel, and (c) GAG normalized to
DNA content per gel encapsulated with chondrocytes at 0 and 3 weeks, with formulations
listed as agarose concentration/PEG-DA concentration (PEG-DA molecular weight).
Halving the PEG-DA concentration in the 6k MW gels resulted in approximately double the
normalized GAG accumulation for the two IPNs, while the pure PEG-DA gel did not
provide a productive environment for chondrocytes in the absence of agarose. Values
represent mean ± standard deviation with n=4. *Values significantly different from week 0
time point (p<0.005), #significant differences (p<0.05) among groups at the same time
point. GAG, glycosaminoglycan.
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Representative live/dead images for (a) agarose and (b) an IPN with 2% agarose and 20%
PEG-DA (6000 Da molecular weight) 24 hours after encapsulation, and (c) an IPN with the
same formulation 3 weeks after encapsulation. High cell viability 24 hours after
encapsulation, even in the IPN formulation with the longest PEG-DA diffusion time and
highest PEG-DA concentration, demonstrates the potential for this encapsulation process to
work well with a wide variety of PEG-DA concentrations and molecular weights. Live cells
are stained green with Calcein AM (green), while dead cells are stained red with ethidium
homodimer-1. Scale bars = 50 µm.
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Maximum strain of agarose and PEG-DA IPNs encapsulated with chondrocytes at 0 and 3
weeks. A total of 9 groups are compared three at a time, grouped as (a) pure 20% PEG-DA
gels with varied molecular weights of 2000 (2k), 3400 (3.4k) and 6000 (6k) Da, (b) IPNs
varying molecular weights, (c) IPNs with varying concentrations of PEG-DA, and (d) IPNs
with varying agarose concentrations. As with maximum stress (Figure 8), cell-laden gels
appeared to have a limit to the amount of strain they could withstand, regardless of the
performance of their acellular counterparts. Formulations listed as agarose concentration/
PEG-DA concentration (PEG-DA molecular weight), and underlines note the same
formulation was shown in a previous panel. Values from acellular gels (taken from Fig. 1b)
included for comparison. *Values significantly different from acellular gels with the same
formulation (p<0.05), #significant differences among groups at the same time point within
the same panel (p<0.05).
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Maximum stress of agarose and PEG-DA IPNs encapsulated with chondrocytes at 0 and 3
weeks. A total of 9 groups are compared three at a time, grouped as (a) pure 20% PEG-DA
gels with varied molecular weights of 2000 (2k), 3400 (3.4k) and 6000 (6k) Da, (b) IPNs
varying molecular weights, (c) IPNs with varying concentrations of PEG-DA, and (d) IPNs
with varying agarose concentrations. Unlike the shear and compressive moduli, values of the
cell-encapsulated gels did not follow the same trends as their acellular counterparts due to an
inability to withstand a stress of more than approximately 1500 kPa. Formulations listed as
agarose concentration/PEG-DA concentration (PEG-DA molecular weight), and underlines
note the same formulation was shown in a previous panel. Values from acellular gels (taken
from Fig. 1a) included for comparison. *Values significantly different from acellular gels
with the same formulation (p<0.05), #significant differences among groups at the same time
point within the same panel (p<0.05).
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Shear moduli of agarose and PEG-DA IPNs encapsulated with chondrocytes at 0 and 3
weeks. A total of 9 groups are compared three at a time, grouped as (a) pure 20% PEG-DA
gels with varied molecular weights of 2000 (2k), 3400 (3.4k) and 6000 (6k) Da, (b) IPNs
varying molecular weights, (c) IPNs with varying concentrations of PEG-DA, and (d) IPNs
with varying agarose concentrations. Cell-laden gels typically followed the same trends as
acellular gels, with little difference between time points. Formulations listed as agarose
concentration/PEG-DA concentration (PEG-DA molecular weight), and underlines note the
same formulation was shown in a previous panel. Values from acellular gels (taken from
Fig. 2a) included for comparison. *Values significantly different from acellular gels with the
same formulation (p<0.05), #significant differences among groups at the same time point
within the same panel (p<0.05), +significant differences between week 0 and week 3 for a
single group (p<0.05).
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Ratio of compressive modulus to shear modulus (E/G) of agarose and PEG-DA IPNs
encapsulated with chondrocytes at 0 and 3 weeks. A total of 9 groups are compared three at
a time, grouped as (a) pure 20% PEG-DA gels with varied molecular weights of 2000 (2k),
3400 (3.4k) and 6000 (6k) Da, (b) IPNs varying molecular weights, (c) IPNs with varying
concentrations of PEG-DA, and (d) IPNs with varying agarose concentrations. Very few
significant differences were found in ideal elastic behavior between cell-laden and acellular
gels. Formulations listed as agarose concentration/PEG-DA concentration (PEG-DA
molecular weight), and underlines note the same formulation was shown in a previous panel.
Values from acellular gels (taken from Fig. 2b) included for comparison. *Values
significantly different from acellular gels with the same formulation (p<0.05), #significant
differences among groups at the same time point within the same panel (p<0.05),
+significant differences between week 0 and week 3 for a single group (p<0.05).
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Table 1










0%/20% (2k)* 0 20 2000
0%/20% (3.4k) 0 20 3400
0%/20% (6k) 0 20 6000
2%/20% (2k) 2 20 2000
2%/20% (3.4k) 2 20 3400
2%/20% (6k)* 2 20 6000
2%/15% (6k) 2 15 6000
2%/10% (6k)* 2 10 6000
5%/20% (6k) 5 20 6000
*
Indicates formulation was analyzed for glycosaminoglycan (GAG) and DNA content.
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Table 2
Summary of the most significant factors that influence each property
Property Most Significant Factor Relationship
Shear Modulus (G) PEG-DA concentration Shear moduli were higher with greater PEG-DA concentration
Compressive Modulus (E) PEG-DA concentration Compressive moduli were higher with greater PEG-DA concentration
Mass swelling ratio (q) PEG-DA concentration Mass swelling ratios were lower with greater PEG-DA concentration
PEG-DA content PEG-DA concentration PEG-DA content was higher with greater PEG-DA concentrationb
Mesh size (ξ) PEG-DA concentration Mesh sizes were lower with greater PEG-DA concentration
Crosslink density (ρx) PEG-DA concentration Crosslink densities were higher with greater PEG-DA concentration
E/G PEG-DA molecular weighta E/G ratios were higher with higher PEG-DA molecular weight
Maximum stress PEG-DA molecular weight Maximum stresses were higher with higher PEG-DA molecular weight
Maximum strain PEG-DA molecular weight Maximum strains were higher with higher PEG-DA molecular weight
a
Agarose concentration also strongly influenced E/G ratios, with an increase in agarose concentration leading to higher E/G ratios.
b
With the exception of one formulation, all IPNs had lower PEG-DA content than pure PEG-DA gels for a given PEG-DA starting concentration
(p<0.05).
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